The Notch ligand Delta-like 1 integrates inputs from TGFbeta/Activin and Wnt pathways

Experimental Cell Research

Volumn 317, Issue 10, 2011, Pages 1368-1381

  Bordonaro, Michael ^a   Tewari, Shruti ^a   Atamna, Wafa ^a   Lazarova, Darina L ^a  

^a Janet Weis Children s Hospital   (United States)

Author keywords

Butyrate; Colon cancer; Delta like 1; Notch; Smad; TGFbeta; Wnt

Indexed keywords

ACTIVIN; BUTYRIC ACID; CONNECTIVE TISSUE GROWTH FACTOR; DELTA LIKE 1; NOTCH RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CANCER CELL; CELL GROWTH; CHROMATIN IMMUNOPRECIPITATION; CLONE; COLON CANCER; CONTROLLED STUDY; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 79955953941     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.03.019     Document Type: Article

References (82)

1. Sancho E., Batlle E., Clevers H. Signaling pathways in intestinal development and cancer. Annu. Rev. Cell Dev. Biol. 2004, 20:695-723.
2. Morin J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275:1787-1790.
3. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell Biochem. Biophys. 1996, 87:159-170.
4. Miyaki M., Iijima T., Kimura J., Yasuno M., Mori T., Hayashi Y., Koike M., Shitara N., Iwama T., Kuroki T. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res. 1999, 59:4506-4509.
5. Roose J., Clevers H. Tcf transcription factors: molecular switches in carcinogenesis. Biochim. Biophys. Acta 1999, 87456:M23-M27.
6. Yochum G.S., McWeeney S., Rajaraman V., Cleland R., Peters S., Goodman R.H. Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells. Proc. Natl. Acad. Sci. USA 2007, 104:3324-3329.
7. Hatzis P., van der Flier L.G., van Driel M.A., Guryev V., Nielsen F., Denissov S., Nijman I.J., Koster J., Santo E.E., Welboren W., Versteeg R., Cuppen E., van de Wetering M., Clevers H., Stunnenberg H.G. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol. Cell. Biol. 2008, 28:2732-2744.
8. Jensen J., Pedersen E.E., Galante P., Hald J., Heller R.S., Ishibashi M., Kageyama R., Guillemot F., Serup P., Madsen O.D. Control of endodermal endocrine development by Hes-1. Nat. Genet. 2000, 24:36-44.
9. Yang Q., Bermingham N.A., Finegold M.J., Zoghbi H.Y. Requirements of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001, 294:2155-2158.
10. Selkoe D., Kopan R. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu. Rev. Neurosci. 2003, 26:565-597.
11. Schweisguth F. Notch signaling activity. Curr. Biol. 2004, 14:R129-R138.
12. Akiyama J., Okamoto R., Iwasaki M., Zheng X., Yui S., Tsuchiya K., Nakamura T., Watanabe M. Delta-like 1 expression promotes goblet cell differentiation in Notch-inactivated human colonic epithelial cells. Biochem. Biophys. Res. Commun. 2010, 393:662-667.
13. Lazarova D.L., Bordonaro M., Sartorelli A.C. Linear relationship between WNT activity -levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Int. J. Cancer 2004, 110:523-531.
14. Brabletz T., Jung A., Hermann K., Günther K., Hohenberger W., Kirchner T. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol. Res. Pract. 1998, 194:701-704.
15. Hlubek F., Brabletz T., Budczies J., Pfeiffer S., Jung A., Kirchner T. Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer. Int. J. Cancer 2007, 121:1941-1948.
16. Verras M., Papandreou I., Lim A.L., Denko N.C. Tumor hypoxia blocks Wnt processing and secretion through the induction of endoplasmic reticulum stress. Mol. Cell. Biol. 2008, 28:7212-7224.
17. Huang D., Du X. Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination. World J. Gastroenterol. 2008, 14:1823-1837.
18. Bordonaro M., Mariadason J.M., Aslam F., Heerdt B.G., Augenlicht L.H. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. Cell Growth Differ. 1999, 713-720.
19. Bordonaro M., Lazarova D.L., Augenlicht L.H., Sartorelli A.C. Cell type- and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate. Int. J. Cancer 2002, 97:42-51.
20. Bordonaro M., Lazarova D.L., Sartorelli A.C. The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. Exp. Cell Res. 2007, 313:1652-1666.
21. E. Soler, C. Andrieu-Soler, E. Boer, J.C. Bryne, S. Thongjuea, E. Rijkers, J. Demmers,W. van Ijcken, and F. Grosveld A systems approach to analyze transcription factors in mammalian cells. (2010) doi:10.1016/j.ymeth.2010.08.002.
22. Lazarova D.L., Bordonaro M., Sartorelli A.C. Transcriptional regulation of the vitamin D (3) receptor gene by ZEB. Cell Growth Differ. 2001, 12:319-326.
23. Bierie B., Moses H.L. TGFbeta and cancer. Cytokine Growth Factor Rev. 2006, 17:29-40.
24. Grady W.M., Myeroff L.L., Swinler S.E., Rajput A., Thiagalingam S., Lutterbaugh J.D., Neumann A., Brattain M.G., Chang J., Kim S.J., Kinzler K.W., Vogelstein B., Willson J.K., Markowitz S. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res. 1999, 59:320-324.
25. Saif M.W., Chu E. Biology of colorectal cancer. Cancer J. 2010, 16:196-201.
26. Riggins G.J., Thiagalingam S., Rozenblum E., Weinstein C.K., Kern S.E., Hamilton S.R., Willson J.K., Markowitz S.D., Kinzler K.W., Vogelstein Test B. Mad-related genes in the human. Nat. Genet. 1996, 13:347-349.
27. Markowitz S., Wang J., Myeroff L., Parsons R., Sun L., Lutterbaugh J., Fan R.S., Zborowska E., Kinzler K.W., Vogelstein B., Brattain M., Willson J.K.V. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995, 268:1336-1338.
28. Thiagalingam S., Lengauer C., Leach F.S., Schutte M., Hahn S.A., Overhauser J., Willson J.K., Markowitz S., Hamilton S.R., Kern S.E., Kinzler K.W., Vogelstein B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet. 1996, 13:343-346.
29. Eppert K., Scherer S.W., Ozcelik H., Pirone R., Hoodless P., Kim H., Tsui L.C., Bapat B., Gallinger S., Andrulis I.L., Thomsen G.H., Wrana J.L., Attisano L. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell Biochem. Biophys. 1996, 86:543-552.
30. Parsons R., Myeroff L.L., Liu B., Willson J.K., Markowitz S.D., Kinzler K.W., Vogelstein B. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res. 1995, 55:5548-5550.
31. Hempen P.M., Zhang L., Bansal R.K., Iacobuzio-Donahue C.A., Murphy K.M., Maitra A., Vogelstein B., Whitehead R.H., Markowitz S.D., Willson J.K., Yeo C.J., Hruban R.H., Kern S.E. Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. Cancer Res. 2003, 63:994-999.
32. Fink S.P., Swinler S.E., Lutterbaugh J.D., Massagué J., Thiagalingam S., Kinzler K.W., Vogelstein B., Willson J.K., Markowitz S. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line. Cancer Res. 2001, 61:256-260.
33. Yanagisawa J., Yanagi Y., Masuhiro Y., Suzawa M., Watanabe M., Kashiwagi K., Toriyabe T., Kawabata M., Miyazono K., Kato S. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 1999, 283:1317-1321.
34. Dai J.L., Schutte M., Bansal R.K., Wilentz R.E., Sugar A.Y., Kern S.E. Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells. Mol. Carcinog. 1999, 26:37-43.
35. Sonoyama K., Pholnukulkit P., Toyoda M., Rutatip S., Kasai T. Upregulation of activin A gene by butyrate in human colon cancer cell lines. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284:G989-G995.
36. Pholnukulkit P., Sonoyama K., Kawabata J. Activin A induces phosphorylation of Smad2 but not complex formation of Smad2 with Smad4 in human colon cancer cell line HT-29. Biosci. Biotechnol. Biochem. 2003, 67:2042-2044.
37. Bahathiq A.O., Stewart R.L., Wells M., Moore H.D., Pacey A.A., Ledger W.L. Production of activins by the human endosalpinx. J. Clin. Endocrinol. Metab. 2002, 87:5283-5289.
38. Hiratochi M., Nagase H., Kuramochi Y., Koh C.S., Ohkawara T., Nakayama K. The Delta intracellular domain mediates TGF-beta/Activin signaling through binding to Smads and has an important bi-directional function in the Notch-Delta signaling pathway. Nucleic Acids Res. 2007, 35:912-922.
39. Ikeuchi T., Sisodia S.S. The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent "gamma-secretase" cleavage. J. Biol. Chem. 2003, 278:7751-7754.
40. LaVoie M.J., Selkoe D.J. The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments. J. Biol. Chem. 2003, 278:34427-34437.
41. Six E., Ndiaye D., Laabi Y., Brou C., Gupta-Rossi N., Israel A., Logeat F. The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma secretase. Proc. Natl. Acad. Sci. USA 2003, 100:7638-7643.
42. Lee Y.J., Swencki B., Shoichet S., Shivdasani R.A. A possible role for the high mobility group box transcription factor Tcf-4 in vertebrate gut epithelial cell differentiation. J. Biol. Chem. 1999, 274:1566-1572.
43. Weise A., Bruser K., Elfet S., Wallmen B., Wittel Y., Wöhrle S., Hecht A. Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets. Nucl. Acids Res. 2010, 38:1964-1981.
44. Galceran J., Sustmann C., Hsu S.C., Folberth S., Grosschedl R. LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis. Genes Dev. 2004, 18:2718-2723.
45. Katoh M., Katoh M. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int. J. Mol. Med. 2006, 17:681-685.
46. Estrach S., Ambler C.A., Lo Celso C., Hozumi K., Watt F.M. Jagged 1 is a beta-catenin target gene required for ectopic hair follicle formation in adult epidermis. Dev. 2006, 133:4427-4438.
47. Kolev V., Kacer D., Trifonova R., Small D., Duarte M., Soldi R., Graziani I., Sideleva O., Larman B., Maciag T., Prudovsky I. The intracellular domain of Notch ligand Delta1 induces cell growth arrest. FEBS Lett. 2005, 579:5798-5802.
48. Zarrinkalam K.H., Stanley J.M., Gray J., Oliver N., Faull R.J. Connective tissue growth factor and its regulation in the peritoneal cavity of peritoneal dialysis patients. Kidney Int. 2003, 64:331-338.
49. Igarashi A., Okochi H., Bradham D.M., Grotendorst G.R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol. Biol. Cell 1993, 4:637-645.
50. Abraham D.J., Shiwen X., Black C.M., Sa S., Xu Y., Leask A. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J. Biol. Chem. 2000, 275:15220-15225.
51. Blom I.E., Goldschmeding R., Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?. Matrix Biol. 2002, 21:473-482.
52. Leask A. A sticky situation: CCN1 promotes both proliferation and apoptosis of cancer cells. J. Cell Commun. 2010, 109-110. Signal.4.
53. Chen S., McLean S., Carter D.E., Leask Test A. The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts. Cell Commun. Signal. 2007, 1:175-183.
54. Chen S., Leask A. Wnt 10b activates the CCN2 promoter in NIH 3T3 fibroblasts through the Smad response element. J. Cell Commun. Signal. 2009, 3:57-59.
55. Wang H., Song K., Sponseller T.L., Danielpour D. Novel function of androgen receptor-associated protein 55/Hic-5 as a negative regulator of Smad3 signaling. J. Biol. Chem. 2005, 280:5154-5162.
56. Chipuk J.E., Cornelius S.C., Pultz N.J., Jorgensen J.S., Bonham M.J., Kim S.J., Danielpour D. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3. J. Biol. Chem. 2002, 277:1240-1248.
57. Bland C.E., Kimberly P., Rand M.D. Notch-induced proteolysis and nuclear localization of the Delta ligand. J. Biol. Chem. 2003, 278:13607-13610.
58. D'Souza B., Miyamoto A., Weinmaster G. The many facets of Notch ligands. Oncogene 2008, 27:5148-5167.
59. Kloth J.N., Fleuren G.J., Oosting J., de Menezes R.X., Eilers P.H.C., Kenter G.G., Gorter A. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines. Carcinogenesis 2005, 26:1493-1502.
60. Zawel L., Dai J.L., Buckhaults P., Zhou S., Kinzler K.W., Vogelstein B., Kern S.E. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell Proteo. 1998, 1:611-617.
61. Datto M.B., Yu Y., Wang X.F. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 1995, 270:28623-28628.
62. Barker N., Huls G., Korinek V., Clevers H. Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. Am. J. Pathol. 1999, 154:29-35.
63. Gregorieff A., Pinto D., Begthel H., Destrée O., Kielman M., Clevers H. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 2005, 129:626-638.
64. Nawshad A., Medici D., Liu C.C., Hay E.D. TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J. Cell Sci. 2007, 120:1646-1653.
65. Luo Q., Kang Q., Si W., Jiang W., Park J.K., Peng Y., Li X., Luu H.H., Luo J., Montag A.G., Haydon R.C., He T.C. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem. 2004, 279:55958-55968.
66. Zhang B., Zhou K.K., Ma J.X. Inhibition of CTGF over-expression in diabetic retinopathy by SERPINA3K via Blocking the WNT/Beta-catenin pathway. Diabetes 2010, 59:1809-1816.
67. Labbé E., Letamendia A., Attisano L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and Wnt pathways. Proc. Natl. Acad. Sci. USA. 2000, 97:8358-8363.
68. Hirota M., Watanabe K., Hamada S., Sun Y., Strizzi L., Mancino M., Nagaoka T., Gonzales M., Seno M., Bianco C., Salomon D.S. Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300. Cell. Signal. 2008, 20:1632-1641.
69. Zhang M., Wang M., Tang X., Li T.F., Zhang Y., Chen D. Smad3 prevents beta-catenin degradation and facilitates beta-catenin nuclear translocation in chondrocytes. J. Biol. Chem. 2010, 285:8703-8710.
70. Labbé E., Lock L., Letamendia A., Gorska A.E., Gryfe R., Gallinger S., Moses H.L., Attisano L. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res. 2007, 67:75-84.
71. Chu C.Y., Chang C.C., Prakash E., Kuo M.L. Connective tissue growth factor (CTGF) and cancer progression. J. Biomed. Sci. 2008, 15:675-685.
72. Yeger H., Perbal B. The CCN family of genes: a perspective on CCN biology and therapeutic potential. J. Cell Commun. Signal. 2007, 1:159-164.
73. Chen P.S., Wang M.Y., Wu S.N., Su J.L., Hong C.C., Chuang S.E., Chen M.W., Hua K.T., Wu Y.L., Cha S.T., Babu M.S., Chen C.N., Lee P.H., Chang K.J., Kuo M.L. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway. J. Cell Sci. 2007, 120:2053-2065.
74. Aikawa T., Gunn J., Spong S.M., Klaus S.J., Korc M. Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol. Cancer Ther. 2006, 5:1108-1116.
75. Chang C.C., Shih J.Y., Jeng Y.M., Su J.L., Lin B.Z., Chen S.T., Chau Y.P., Yang P.C., Kuo M.L. Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J. Natl. Cancer Inst. 2004, 96:364-375.
76. Jiang W.G., Watkins G., Fodstad O., Douglas-Jones A., Mokbel K., Mansel R.E. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endo. Relat. Cancer. 2004, 11:781-791.
77. Hishikawa K., Oemar B.S., Tanner F.C., Nakaki T., Lüscher T.F., Fujii Test T. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J. Biol. Chem. 1999, 274:37461-37466.
78. Ernst A., Campos B., Meier J., Devens F., Liesenberg F., Wolter M., Reifenberger G., Herold-Mende C., Lichter P., Radlwimmer B. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene 2010, 29:3411-3422.
79. Hishikawa K., Oemar B.S., Tanner F.C., Nakaki T., Fujii T., Lüscher T.F. Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation 1999, 100:2108-2112.
80. Tang Y., Urs S., Boucher J., Bernaiche T., Venkatesh D., Spicer D.B., Vary C.P., Liaw L. Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J. Biol. Chem. 2010, 285:17556-17563.
81. Blokzjil A., Dahlqvist C., Reissman E., Falk A., Moliner A., Lendahl U., Ibanez C.F. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J. Cell Biol. 2003, 163:723-728.
82. Sun Y., Lowther W., Kato K., Bianco C., Kenney N., Strizzi L., Raafat D., Hirota M., Khan N.I., Bargo S., Jones B., Salomon D., Callahan R. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene 2005, 24:5365-5374.